Companies: 10,153     total market cap: S$150.657 T
🇩🇪 Deutsch🇫🇷 Français
$USD🇺🇸€EUR🇪🇺₹INR🇮🇳£GBP🇬🇧$CAD🇨🇦$AUD🇦🇺$NZD🇳🇿$HKD🇭🇰
Neurocrine Biosciences
NBIX
#1457
Rank
S$15.96 B
Marketcap
🇺🇸 United States
Country
$157.67
Share price
-4.42%
Change (1 day)
7.61%
Change (1 year)
💊 Pharmaceuticals🧬 Biotech
Categories
Neurocrine Biosciences is an American biopharmaceutical company that develops treatments for neurological and endocrine-related diseases and disorders.

Earnings for Neurocrine Biosciences (NBIX)

Earnings in 2024 (TTM): S$0.86 Billion

According to Neurocrine Biosciences 's latest financial reports the company's current earnings are S$2.24 Billion. In 2023 the company made an earning of S$0.48 Billion, an increase over its 2022 earnings that were of S$0.29 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Neurocrine Biosciences from 1996 to 2024

Annual earnings

Year Earnings Change
2024 (TTM) S$0.86 B79.79%
2023 S$0.48 B62.85%
2022 S$0.29 B73.74%
2021 S$0.17 B-8.82%
2020 S$0.18 B77.78%
2019 S$0.10 B49.83%
2018 S$70.31 M-142.57%
2017 -S$0.17 Billion-14.73%
2016 -S$0.2 Billion53.15%
2015 -S$0.13 Billion46.25%
2014 -S$86.48 Million29.66%
2013 -S$66.7 Million-3530.8%
2012 S$1.94 M-95.73%
2011 S$45.54 M
2009 -S$64.03 Million-45.38%
2008 -S$0.12 Billion-58.87%
2007 -S$0.29 Billion87.3%
2006 -S$0.16 Billion351.97%
2005 -S$33.67 Million-52.09%
2004 -S$70.27 Million-10.98%
2003 -S$78.93 Million
2001 -S$58.92 Million
1999 -S$26.58 Million108.32%
1998 -S$12.76 Million
1996 S$3.89 M

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Repligen
RGEN
S$28.8 M-96.73%🇺🇸 USA
Royalty Pharma
RPRX
S$1.63 B 85.21%🇬🇧 UK
Palatin Technologies
PTN
-S$40.82 Million-104.63%🇺🇸 USA
Eli Lilly
LLY
S$13.62 B 1,445.68%🇺🇸 USA
AbbVie
ABBV
S$9.48 B 975.99%🇺🇸 USA
Pfizer
PFE
-S$1.63 Billion-284.56%🇺🇸 USA
ANI Pharmaceuticals
ANIP
S$47.67 M-94.59%🇺🇸 USA
Athersys
ATHX
-S$56.07 Million-106.36%🇺🇸 USA

What is the market capitalization of a company?

The market capitalization sometimes referred as Marketcap, is the value of a publicly listed company.
In most cases it can be easily calculated by multiplying the share price with the amount of outstanding shares.

DISCLAIMER

CompaniesMarketCap is not associated in any way with CoinMarketCap.com
Stock prices are delayed, the delay can range from a few minutes to several hours.
Company logos are from the CompaniesLogo.com logo database and belong to their respective copyright holders. Companies Marketcap displays them for editorial purposes only.

Contact

For inquiries or if you want to report a problem write to hello@8marketcap.com

Links

- Privacy policy

- Terms and conditions

© 2024 CompaniesMarketcap.com